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SHORT AND LONG-TERM EFFECT OF CHONDROCYTE VERSUS
MESENCHYMAL STEM CELLS GROWN ONTO A HYALURONAN-
BASED SCAFFOLD IN IN A RABBIT OSTEOARTHRITIS MODEL
G. Desando, Jr., C. Cavallo, Jr., I. Bartolotti, Jr., M. Tschon, Sr.,
G. Giavaresi, Sr., L. Martini, Sr., M. Fini, Sr., B. Grigolo, Sr.. Istituto
Ortopedico Rizzoli, Bologna, Italy
Purpose: Osteoarthritis (OA) is a major health issue worldwide due to
the increasing age of active population and the impact on patients' daily
life. Cartilage and synovial alterations are important factors involved in
OA progression. Despite the advancements in this ﬁeld, there is a largely
unmet medical need for durable disease-modifying treatments. Cell-
based therapies have become thriving therapeutic options for OA but
nevertheless the choice of the suitable cell candidate is a source of
debate. The purpose of this work was aimed to compare the regener-
ative potential of chondrocytes versus Mesenchymal Stem Cells (MSC),
grown onto a hyaluronan-based scaffold (Hyaff-11) in counteracting OA
progression in an experimental OA rabbit model at short and long-term
follow-ups.
Methods: Adult male New Zealand rabbits were enrolled in this study
according to European and Italian laws for animal experimentation. A
mild grade of OA was induced surgically through bilateral Anterior
Cruciate Ligament Transection at 8 weeks. Chondrocytes and MSC were
isolated from rabbit articular cartilage and bone marrow respectively,
grown in monolayer cultures, seeded onto Hyaff-11 (HA) and trans-
planted after OA onset. Animals were divided into two groups: 1)
chondrocyte-seeded HA (Chondro-HA) and 2) MSC-seeded HA (MSC-
HA). Empty HAwas used as control. Animals were euthanized at 3 and 6
months. Cartilage and synovia were assessed by histology supported by
modiﬁed Mankin score and histomorphometric analyses. Protein
expression of collagen type I, II and X, MMP-1, MMP-3 and MMP-13
were assessed by immunohistochemistry. The General Linear Model
with Sidak correction was used to compare the two cell-based
therapies.
Results: At 3 months, chondro-HA group displayed an active con-
tribution in reducing OA changes especially on cartilage with an
improvement of tissue morphology, extracellular matrix organization
and cell distribution compared to MSC-HA-one (p<0.05); the effects on
synovia were less pronounced. Further analyses conﬁrmed these ﬁnd-
ings with a decrease of MMP-3, MMP-13 and TNF-a mainly in cartilage
(p<0.05). A reduction of hypertrophic processes was evident in cartilage
for both cell treatments compared to HA (p<0.05). At 6 months, MSC-
HA therapy displayed the best macroscopic and histological ﬁndings on
cartilage and synovial tissues than chondro-HA-one (p<0.05). This last
displayed some endochondral ossiﬁcation processes and thickening of
the subchondral bone plate in femur and hyperplasia and ﬁbrous
reactions in synovia. Moreover, a decreased presence of MMP-1, -3, -13,
TNF-a and some hypertrophic markers was evident for MSC-HA therapy
at both tissue level. Conversely, an increase of collagen X and alkaline
phosphatase was noticed for chondro-HA therapy at long-term follow-up. In general, various degrees of tissue remodeling were noticed with
HA treatment.
Conclusions: Our ﬁndings revealed a positive effect of chondro-HA and
MSC-HA therapies in promoting cartilage healing and counteracting
some OA inﬂammatory and degenerative processes. However, the efﬁ-
cacy of chondro-HA therapy was focused mainly on cartilage tissue and
was time-dependent probably due to: 1) chondrocyte changes towards
a ﬁbrous and hypertrophic phenotype during the time; and 2) low
effectiveness on synovia. On the other hand, MSC-HA treatment had a
wider spectrum of action than chondro-HA, exerting its healing
potential not only on cartilage tissue but also on synovia. Thus, the use
of chondrocytes could be suggested in the early stage of OA when a
precocious action is mandatory; whereas the use of MSC could be more
appropriate at both early and moderate stages of OA, since they would
seem to guarantee a more stable repair during the time.
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CHARACTERISATION OF ENGRAFTED MESENCHYMAL STEM CELLS
POST INTRA-ARTICULAR INJECTION IN HEALTHY MOUSE JOINT
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F. Barry y. yREMEDI (NUI), Galway, Ireland; z Flow Cytometry Core Facility,
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Purpose: Due to its avascular nature and low chondrocyte proliferation,
cartilage has little self-repair capacity. As such, injuries to the articular
surface may lead to sustained degeneration as in osteoarthritis (OA).
Mesenchymal stem cells (MSCs) are considered a promising tool for the
repair of damaged cartilage, due to their chondrogenic differentiation
potential or secretory proﬁle, and have been shown to engraft and
promote regeneration when locally administered. The aim of this study
was to assess the inﬂuence of the articular microenvironment on the
viability and differentiation potential of locally delivered MSCs, in order
to study the molecular mechanisms of repair in a murine model of OA.
Methods: GFP-expressing MSCs were isolated from C57BL/6-Tg(UBC-
GFP)30Scha/J mice and expanded in culture. After 5-6 passages, a single
dose of 2105 cells suspended in Minimum Essential Medium (MEM)-
alpha was intra-articularly delivered into healthy 8-week-old C57BL/6
mice. Control animals received MEM-a only. After three days, knee
joints were either decalciﬁed and processed for histology or digested in
a solution of 2 mg/ml Collagenase type I to obtain a single cell sus-
pension. Cell suspensions from 4 knee joints were pooled and sorted
based on ﬂuorescence intensity using the BD FACS Aria II. GFPþ MSCs,
pre- and post-intra-articular (post-IA) injection, underwent CFU-F assay
and osteogenic/chondrogenic/adipogenic potential evaluation through
culturing in differentiative media.
Results: 1.63% of the injected cells were successfully retrieved by cell
sorting, with 82.1% sample purity. Histological analysis showed
engraftment of single cells, particularly after three days, at the level of
articular cartilage and synovial membrane (Fig.1), as well as attachment
to ligament. The sorted cells were able to grow in culture, retaining
ﬂuorescence and a spindle-shaped morphology (Fig. 2). Post-IA MSCs
showed a slightly higher growth potential and a more than doubled
clonogenic potential. Post-IA MSCs only formed immature adipocytes
with limited fat content and no fully formed droplets, but semi-quan-
tiﬁcation did not show any loss in adipogenic differentiation potential.
Post-IA cells also showed a slight but not signiﬁcant decrease in
osteogenic potential and post-IA chondrogenic pellets exhibited less
extensive Safranin-O staining, indicating a lower production of pro-
teoglycan (GAG) in the extracellular matrix. However, assessment of the
GAG/DNA ratio indicated an increase in chondrogenic differentiation
after exposure to the synovial environment.
Conclusions: It was shown that MSCs can be administered, tracked and
retrieved from murine knee joints. Observed ﬂuorescence originates
from injected cells and is not the result of phagocytosis from the host
immune system. After exposure to the synovial environment, syngeneic
cells are not only able to integrate in the tissue but also retain a similar
behavior to MSCs in culture. In particular, the increased clonogenic
potential suggests that the synovial environment selects a narrower
population of quiescent progenitor cells. IA-injected cells, while main-
taining the capacity for forming osteocytes and adipocytes showed
increased chondrogenic capacity. This suggests a potential beneﬁt for
degenerative conditions that affect articular cartilage. These results,
obtained in healthy animals, will serve as a proof-of-principle to study
the changes that MSCs undergo in the synovial microenvironment of a
murine model of OA.
